Biokinetic and toxicodynamic modelling and its role in toxicological research and risk assessment

Alternatives to Laboratory Animals

Volumn 31, Issue 3, 2003, Pages 277-281

  Blaauboer, Bas J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Biokinetic modelling; In vitro models; Integrated testing; Risk assessment

Indexed keywords

BIOTRANSFORMATION; COMPUTER MODEL; CONFERENCE PAPER; CYTOTOXICITY; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZATION; TOXICITY TESTING; TOXICOKINETICS; VALIDATION PROCESS;

ANIMALIA;

EID: 0043198212     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290303100310     Document Type: Conference Paper

References (30)

1. Kroes, R. & Feron, V.J. (1990). Toxicity testing: strategies and conduct. In Progress in Predictive Toxicology (ed. D.B. Clayson, I.C. Munro, P. Shubit & J.A. Seenberg), pp. 15-39. Amsterdam, The Netherlands: Elsevier.
2. OECD (1993). Guidance Document for the Development of OECD Guidelines for the Testing of Chemicals, Monograph No. 76. Paris, France: OECD.
3. Balls, M. (1998). Mechanistic approaches and the development of alternative toxicity test methods. Environmental Health Perspectives 106, Suppl. 2, 453-457.
4. Blaauboer, B.J. (2002). The applicability of in vitro-derived data in hazard identification and characterisation of chemicals. Environmental Toxicology and Pharmacology 11, 213-225.
5. Harries, H.M., Fletcher, S.T., Duggan, C.M. & Baker, V.A. (2001). The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicology in Vitro 15, 399-405.
6. Blaauboer, B.J., Balls, M., Barratt, M., Casati, S., Coecke, S., Mohamed, M.K., Moore, J., Rall, D., Smith, K.R., Tennant, S., Schwetz, B.A., Stokes, W.S. & Younes, M. (1998). 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies and conceptual issues. Environmental Health Perspectives 106, Suppl. 2, 413-418.
7. Worth, A.P. & Balls, M., eds (2002). Alternative (non-animal) methods for chemicals testing: current status and future prospects. A report prepared by ECVAM and the ECVAM Working Group on Chemicals. ATLA 30, Suppl. 1, 1-125.
8. MacGregor, J.T., Collins, J.M., Sugiyama, Y., Tyson, C.A., Dean, J., Smith, L., Andersen, M., Curren, R.D., Houston, J.B., Kadlubar, F.F., Kedderis, G.L., Krishnan, K., Li, A.P., Parchment, R.E., Thummel, K., Tomaszewski, J.E., Ulrich, R., Vickers, A.E. & Wrighton, S.A. (2001). In vitro human tissue models in risk assessment: a report of a consensus-building workshop. Toxicological Sciences 59, 17-36.
9. Barratt, M.D. (2000). Prediction of toxicity from chemical structure. Cell Biology and Toxicology 16, 1-13.
10. Ridings, J.E., Barratt, M.D., Cary, R., Earnshaw, C.G., Eggington, C.E., Ellis, M.K., Judson, P.N., Langowski, J.J., Marchant, C.A., Payne, M.P., Watson, W.P. & Yih, T.D. (1996). Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. Toxicology 106, 267-279.
11. Benfanati, E. & Gini, G. (1997). Computational predictive programs (expert systems) in toxicology. Toxicology 119, 213-225.
12. Barratt, M.D. (1996). Quantitative structure-activity relationships for skin irritation and corrosivity of neutral and electrophilic organic chemicals. Toxicology in Vitro 10, 247-256.
13. Barratt, M.D. (1996). Quantitative structure-activity relationships (QSARs) for skin corrosivity of organic acids, bases and phenols: principal components and neural network analysis of extended datasets. Toxicology in Vitro 10, 85-94.
14. Barratt, M.D., Dixit, M.B. & Jones, P.A. (1996). The use of in vitro cytotoxicity measurements in QSAR methods for the prediction of the skin corrosivity potential of acids. Toxicology in Vitro 10, 283-290.
15. Clewell, H.J. & Andersen, M.E. (1996). Use of physiologically based pharmacokinetic modelling to investigate individual versus population risk. Toxicology 111, 315-329.
16. Andersen, M.E., Clewell, H. & Krishnan, K. (1995). Tissue dosimetry, pharmacokinetic modelling, and interspecies scaling factors. Risk Analysis 15, 533-537.
17. Faller, T.H., Csanady, G.A., Kreuzer, P.E., Baur, C.M. & Filser, J.G. (2001). Kinetics of propylene oxide metabolism in microsomes and cytosol of different organs from mouse, rat and humans. Toxicology and Applied Pharmacology 172, 62-74.
18. DeJongh, J., Nordin-Andersson, M., Ploeger, B. & Forsby, A. (1999). Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. Toxicology and Applied Pharmacology 158, 261-268.
19. Geiss, K.T. & Frazier, J.M. (2001). QSAR modelling of oxidative stress in vitro following hepatocyte exposures to halogenated methanes. Toxicology in Vitro 15, 557-563.
20. Frazier, J.M. (1994). The role of mechanistic toxicology in test method validation. Toxicology in Vitro 8, 787-791.
21. Patlewicz, G.Y., Rodford, R.A., Ellis, G. & Barratt, M.D. (2000). A QSAR model for the eye irritation of cationic surfactants. Toxicology in Vitro 14, 79-84.
22. Blaauboer, B.J., Barratt, M.D. & Houston, J.B. (1999). The integrated use of alternative methods in toxicological risk evaluation. ECVAM integrated testing strategies task force report 1. ATLA 27, 229-237.
23. Blaauboer, B.J. (2003). The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic modelling as a tool in hazard and risk assessment. A commentary. Toxicology Letters 138, 161-171.
24. Walum, E., Balls, M., Bianchi, V., Blaauboer, B., Bolcsfoldi, G., Guillouzo, A., Moore, G.A., Odland, L., Reinhardt, C. & Speilmann, H. (1992). ECITTS: an integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA 20, 406-428.
25. DeJongh, J., Forsby, A., Houston, J.B., Beckman, M., Combes, R. & Blaauboer, B.J. (1999). An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test method: overview of a prevalidation study based on the ECITTS project. Toxicology in Vitro 13, 549-554.
26. Blaauboer, B.J., Forsby, A., Houston, J.B., Beckman, M., Combes, R.D. & DeJongh, J. (2000). An integrated approach to the prediction of systemic toxicity using biokinetic models and biological in vitro test methods. In Progress in the Reduction Refinement and Replacement of Animal Experimentation (ed. M. Balls, A-M. van Zeller and M.E. Halder), pp. 525-536. Amsterdam, The Netherlands: Elsevier.
27. DeJongh, J., Verhaar, H.J. & Hermens, J.L.M. (1998). Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs). Toxicological Sciences 45, 26-32.
28. Clemedson, C., Barile, F.A., Chesné, C., Cottin, M., Curren, R., Ekwall, B., Ferro, M., Gómez-Lechón, M.J., Imai, K., Janus, J., Kemp, R.B., Kerszman, G., Kjellstrand, P., Lavrijsen, K., Logemann, P., McFarlane-Abdulla, E., Roguet, R., Segner, H., Thuvander, A., Walum, E. & Ekwall, B. (2000). MEIC evaluation of acute systemic toxicity. Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays. ATLA 28, Suppl. 1, 161-200.
29. Clemedson, C., Nordin-Andersson, M., Bjerregaard, H.F., Clausen, J., Forsby, A., Gustafsson, H., Hansson, U., Isomaa, B., Jørgensen, C., Kolman, A., Kotova, N., Krause, G., Kristen, U., Kurppa, K., Romert, L. & Scheers, E. (2002). Development of an in vitro test battery for the estimation of acute human systemic toxicity: an outline of the EDIT project. ATLA 30, 313-321.
30. Combes, R., Barratt, M. & Balls, M. (2003). An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system. ATLA 31, 7-19.